Indonesia becomes the first country in the world to approve the protein-based Novavax COVID-19 vaccine, which will be manufactured by the Serum Institute of India
Indonesia becomes the first country in the world to approve the protein-based Novavax COVID-19 vaccine, which will be manufactured by the Serum Institute of India.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan to read this report and the complete Premium retrospective archive.
HealthIndonesia becomes the first country in the world to approve the protein-based Novavax COVID-19 vaccine, which will be manufactured by the Serum Institute of India
View Premium plansBrowse free archive reportsIndonesia becomes the first country in the world to approve the protein-based Novavax COVID-19 vaccine, which will be manufactured by the Serum Institute of India.